Transmedics Group Stock Performance
| TMDX Stock | USD 121.46 2.73 2.30% |
On a scale of 0 to 100, TransMedics holds a performance score of 17. The entity has a beta of 1.23, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, TransMedics will likely underperform. Please check TransMedics' downside variance, and the relationship between the total risk alpha and daily balance of power , to make a quick decision on whether TransMedics' existing price patterns will revert.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in TransMedics Group are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, TransMedics showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 6.48 | Five Day Return 22.48 | Year To Date Return 78.54 | Ten Year Return 430.99 | All Time Return 430.99 |
1 | ScottScott Attorneys at Law LLP Reminds Investors of Its Securities Class Action Against TransMedics Group, Inc. | 04/08/2025 |
2 | DEADLINE NEXT WEEK Berger Montague Advises TransMedics Investors to Contact the Firm Before April 15, 2025 | 04/11/2025 |
3 | Shareholders of TransMedics Group, Inc. Should Contact The Gross Law Firm Before April 15, 2025 ... | 04/15/2025 |
4 | 1 Beaten-Down Stock to Buy Right Now and Hold for a Decade | 04/24/2025 |
5 | Hsbc Holdings PLC Has 5.45 Million Stock Position in TransMedics Group, Inc. | 04/29/2025 |
6 | Insights Into TransMedics Q1 Wall Street Projections for Key Metrics | 05/05/2025 |
7 | TransMedics Group Inc Q1 2025 Everything You Need To Know Ahead Of Earnings | 05/07/2025 |
8 | TransMedics Increases 2025 Revenue Outlook to 565-585 Million TMDX Stock News | 05/08/2025 |
9 | TransMedics Group Rating Maintained by Oppenheimer TMDX Stock News | 05/09/2025 |
| Begin Period Cash Flow | 395.3 M |
TransMedics | Build AI portfolio with TransMedics Stock |
TransMedics Relative Risk vs. Return Landscape
If you would invest 6,952 in TransMedics Group on February 12, 2025 and sell it today you would earn a total of 4,921 from holding TransMedics Group or generate 70.79% return on investment over 90 days. TransMedics Group is currently generating 0.9599% in daily expected returns and assumes 4.4331% risk (volatility on return distribution) over the 90 days horizon. In different words, 39% of stocks are less volatile than TransMedics, and 81% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
TransMedics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for TransMedics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as TransMedics Group, and traders can use it to determine the average amount a TransMedics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2165
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TMDX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.43 actual daily | 39 61% of assets are more volatile |
Expected Return
| 0.96 actual daily | 19 81% of assets have higher returns |
Risk-Adjusted Return
| 0.22 actual daily | 17 83% of assets perform better |
Based on monthly moving average TransMedics is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TransMedics by adding it to a well-diversified portfolio.
TransMedics Fundamentals Growth
TransMedics Stock prices reflect investors' perceptions of the future prospects and financial health of TransMedics, and TransMedics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on TransMedics Stock performance.
| Return On Equity | 0.19 | ||||
| Return On Asset | 0.031 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 3.98 B | ||||
| Shares Outstanding | 33.83 M | ||||
| Price To Book | 14.17 X | ||||
| Price To Sales | 8.23 X | ||||
| Revenue | 441.54 M | ||||
| Gross Profit | 262.08 M | ||||
| EBITDA | 69.95 M | ||||
| Net Income | 35.46 M | ||||
| Cash And Equivalents | 204.46 M | ||||
| Cash Per Share | 6.41 X | ||||
| Total Debt | 518.29 M | ||||
| Debt To Equity | 0.36 % | ||||
| Current Ratio | 12.11 X | ||||
| Book Value Per Share | 6.80 X | ||||
| Cash Flow From Operations | 48.8 M | ||||
| Earnings Per Share | 1.07 X | ||||
| Market Capitalization | 4.02 B | ||||
| Total Asset | 804.08 M | ||||
| Retained Earnings | (468.24 M) | ||||
| Working Capital | 437.3 M | ||||
About TransMedics Performance
Evaluating TransMedics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if TransMedics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if TransMedics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 94.69 | 89.95 | |
| Return On Tangible Assets | 0.04 | 0.05 | |
| Return On Capital Employed | 0.05 | 0.05 | |
| Return On Assets | 0.04 | 0.05 | |
| Return On Equity | 0.16 | 0.15 |
Things to note about TransMedics Group performance evaluation
Checking the ongoing alerts about TransMedics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for TransMedics Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| TransMedics Group appears to be risky and price may revert if volatility continues | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: TransMedics Group Rating Maintained by Oppenheimer TMDX Stock News |
- Analyzing TransMedics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether TransMedics' stock is overvalued or undervalued compared to its peers.
- Examining TransMedics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating TransMedics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of TransMedics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of TransMedics' stock. These opinions can provide insight into TransMedics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for TransMedics Stock Analysis
When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.